Tuesday, June 27, 2006

Tech Link (Chipset): nForce 590 SLI Intel Edition: NVIDIA prepares an Intel 975X Killer

A new article has just been posted over at AMDTech, and it's not about any Chipzilla chipset, but a whole new vanilla: NVIDIA*. It is not something new that NVIDIA* plunged in on the Chipzilla users, they have done it in the past (and failed miserably) and goes head-on against top dog Chipzilla chipsets. The past motherboard based on this chipset were not only pricey, but plagued with stability issues, specially on overclock settings (which, it also does very poorly).

AMDTech used a lowly Chipzilla processor (an Intel® Pentium® D 805 processor), overclocked it till it reaches 197FSB. Hmmm, something fishy is going on here, I know I haven't read the whole article but hey, why not overclock something better, like, an Intel® Pentium® D Extreme Edition series(yeah, they said they are going to make a follow up yada yada yada)? I smell memory compatibility or stability issue. But if you're interested, head on over to the site, where all Chipzilla products always end up having negative stains.
Click on image for larger version

NVIDIA has certainly had its share of success in the AMD world and started making inroads in the Intel market space late last year with their first nForce4 for Intel chipsets. A few months ago NVIDIA updated their Intel platform with a revised stepping of their nForce4 Intel chipset along with a slightly different marketing strategy by going after the hearts and wallets of potential Intel customers with mainstream products. The nForce4 Intel SLI XE and Ultra chipsets were very good performers at excellent prices and found their way into several manufacturers' boards this last quarter. However, the continued reliance upon the NetBurst architecture and Intel's entrenchment in the corporate market has resulted in a situation where the nForce4 Intel product is constantly on the outside looking in for market acceptance in both the performance and business sectors.


Source:AMDTech

No comments: